How AI is Revolutionizing Global Pharma
CEO Roland Sandström Reveals 50-Year Transformation
How AI is Revolutionizing Global Pharma
CEO Roland Sandström Reveals 50-Year Transformation
Roland Sandström, CEO of GHN Pharma with 50 years in pharmaceuticals, reveals how AI is dismantling Big Pharma’s monopoly and enabling small companies to compete globally. From his early days when everything was manual to today’s AI-powered drug development, he shares unprecedented insights into the pharmaceutical industry’s rapid transformation. Roland Sandström has built and sold three pharmaceutical companies over five decades, witnessing the industry evolve from paper-based processes to AI-driven innovation. As CEO of GHN Pharma, he leads a global network spanning 90 countries, helping pharmaceutical companies navigate complex international markets while leveraging cutting-edge technology. In this eye-opening interview,
he explains:
◽ ️ How AI is reducing drug development timelines from years to months
◽ ️ Why Big Pharma companies are becoming “big banks” rather than innovators
◽ ️ How small pharmaceutical companies can now compete with industry giants
◽ ️ The hidden world of parallel importers disrupting European medicine supply
◽ ️ Why rare disease treatments are becoming the new pharmaceutical goldmine
◽ ️ How personalized medicine will revolutionize patient care within years
◽ ️ The future of pharmaceutical sales without traditional sales force